Clinical Pharmacology & Biopharmaceutics
Open Access

Modulating Mitochondrial Function: Implications for Clinical Pharmacology

Received Date: Feb 02, 2024 / Published Date: Feb 29, 2024

Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156

Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 0  . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF

Mitochondria play a pivotal role in cellular energy production, metabolism, and signaling, making them attractive targets for therapeutic intervention in various diseases. This abstract explores the implications of modulating mitochondrial function for clinical pharmacology. Dysregulation of mitochondrial activity is implicated in numerous disorders, including neurodegenerative diseases, metabolic syndromes, cardiovascular disorders, and cancer. Targeting mitochondrial function holds promise for slowing disease progression and improving patient outcomes across these diverse pathologies. Pharmacological interventions aimed at enhancing mitochondrial biogenesis, improving mitochondrial quality control mechanisms, or modulating mitochondrial metabolism offer novel therapeutic strategies. Challenges such as drug specificity, off-target effects, and understanding mitochondrial dynamics remain to be addressed. However, advancements in drug delivery and biomarker development offer avenues for overcoming these obstacles. Overall, modulating mitochondrial function represents a promising approach in clinical pharmacology, offering potential for personalized and effective treatments across a spectrum of diseases.

Keywords